Mersaco is pleased to announce a strategic collaboration with Biofinpharma a pharmaceutical company specialized in various therapeutic areas. This collaboration aims to enhance the availability of a wide range of products in the Lebanese market, ensuring better access to essential medications for patients and healthcare professionals.

Under this collaboration, Mersaco will leverage its extensive distribution network and market expertise to ensure that Biofinpharma’s portfolio reaches public and private institutions across Lebanon.

Both companies share a deep commitment to advancing healthcare standards and delivering significant quality to the community. By adding Biofinpharma’s potfolio with Mersaco’s robust distribution capabilities, the collaboration seeks to optimize the availability of treatments that address various therapeutic areas.

Dr. Walid Mroueh, CEO of Mersaco, commented, “We are excited to collaborate with Biofinpharma, a company that shares our vision for improving patient outcomes. This partnership is a significant step forward in our mission to enhance the quality of healthcare in Lebanon.”

About Mersaco

Mersaco is a leading pharmaceutical distributor in Lebanon, dedicated to providing a comprehensive range of pharmaceutical products and healthcare solutions. With a commitment to excellence and a customer-centric approach, Mersaco partners with global and local pharmaceutical companies to ensure the reliable supply of high-quality medications across the country.

About Biofinpharma

Since 2005 Biofinpharma has been active in the pharmaceutical industry in the Middle East and Africa regions.  It helps their industrial partners and suppliers to develop and test innovative OTC natural and eco-friendly products manufactured in Europe and tested in UK.